MAPT and Alzheimer disease: First, while we create a framework that estimates an individual’s risk of progression to AD based exclusively on structural MRI, we do not rely on demographic data such as years of education or on other imaging such as tau or amyloid-PET, diffusion imaging, or functional MRI.